PETALING JAYA: As the public continues to take a cautious approach towards the heterologous (mix-and-match approach) Covid-19 booster shots here, such shots have been approved by health regulators in the United States and Europe for eligible individuals.
The US Centers for Disease Control and Prevention has authorised booster doses of Pfizer, Moderna and Johnson & Johnson. Its recommendations also approve heterologous dosing for booster shots.
These recommendations are for individuals above 65 years, those above 18 who live in long-term care settings, have underlying medical conditions or those who work or live in high-risk settings.
Eligible individuals who have received a Pfizer or Moderna vaccine shot can obtain a booster shot six months after their primary series, while those who have received the Johnson & Johnson vaccine can get a booster shot two months after their primary series.
Eligible individuals can also choose which vaccine to receive as a booster dose.
According to NBC news, the US Food and Drug Administration is also expected to authorise Pfizer’s Covid-19 booster shot for all adults.
Israel, which has one of the highest vaccinated populations in the world, has rolled out booster jabs across its entire population.
The European Medicines Agency has also approved Pfizer and Moderna as booster vaccines, especially for those with weakened immune systems.
